Hi ohm. One of the things on that list was "any material impairment." Now you have to know that depending on what side of the argument one is on, we lawyers either LOVE or HATE vague language like that.
On the one hand, I could argue that CD12 not meeting its primary endpoint is a material impairment because it will change the share price and value of the company immediately and investors would want this information in order to make decisions.
On the other hand, I could argue that CD12 results, if not positive, are not a material impairment because HIV has a strong chance of approval and that is really what CYDY is all about for the immediate future, HIV, and covid was really an after-thought/happy accident for CYDY anyway.